Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Goodbody Health Ltd GDBYF

Goodbody Health Ltd is a wellness company operating in both COVID testing in the United Kingdom and as a vertically integrated cannabinoid CBD company that operates in the United Kingdom and the European Union. It has interests in COVID testing clinics, CBD extraction, wholesale bulk isolate, and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs.


GREY:GDBYF - Post by User

Comment by lscfaon Apr 21, 2020 7:06pm
74 Views
Post# 30936613

RE:RE:RE:Sativa group

RE:RE:RE:Sativa groupUndervalues STIL at $9.7 mil. Co. has spent over $20 mil to get extraction plants operational. 

$18 mil for Sativa (65%) + $9.7 mil for STIL (35%)  of merged co. = $27.7 mil.      
lscfa wrote:

9x sales is way too much considering not profitable any time soon.   See image. God damn STIL mgmt must be desperate,


 

 

lscfa wrote: Paying 9x sales is too much.......

 

Accroche wrote: Looks like a good acquisition to market the production of CBD with shelves products. But at what price??? Is it too expensive or faiur value?

 




<< Previous
Bullboard Posts
Next >>